Xcout IntelBone Biologics Corp
Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion Device, intended for spinal fusion interventions in skeletally mature individuals experiencing single-level degenerative disc disease within the L4-S1 spinal segments. This versatile platform technology also holds the potential to deliver superior outcomes across a wide spectrum of surgical specialties, including spinal, various orthopedic fields, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. Bone Biologics holds a licensing agreement with the UCLA Technology Development Group, which authorizes the development and commercialization of NELL-1 for its spinal fusion applications. The firm was established in 2004 and is based in Burlington, Massachusetts.
Subscribe to see Bone Biologics Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Bone Biologics Corp at a glance
Bone Biologics Corp is a biotech company headquartered in Burlington, United States. It is publicly listed (BBLG) with a market capitalisation of $2M. Xcout tracks 12 named people at Bone Biologics Corp, including Jeffrey Frelick (Chief Executive Officer & President).
Bone Biologics Corp leadership
- Jeffrey FrelickChief Executive Officer & President
- Deina H. WalshChief Financial Officer
- B Chia SooDirector
- Bret HankeyDirector
- Bruce StroeverDirector
- Don HankeyDirector
6 more named people on record for Bone Biologics Corp, with roles, board committees and tenure — see the full roster →
Get Bone Biologics Corp's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Bone Biologics Corp in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access